Treatment with cabergoline is associated with weight loss in patients with hyperprolactinemia.

Obesity research

Volumn 11, Issue 2, 2003, Pages 311-312

  Korner, Judith ^a   Lo, Janet ^a   Freda, Pamela U ^a   Wardlaw, Sharon L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT; CABERGOLINE; ERGOLINE DERIVATIVE;

FEMALE; HUMAN; HYPERPROLACTINEMIA; LETTER; MALE; WEIGHT REDUCTION;

ANTI-OBESITY AGENTS; ERGOLINES; FEMALE; HUMANS; HYPERPROLACTINEMIA; MALE; WEIGHT LOSS;

EID: 0041728947     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2003.46     Document Type: Letter

References (0)